Warby Parker (WRBY) Preferred Stock Liabilities (2020 - 2021)
Warby Parker's (WRBY) quarterly Preferred Stock Liabilities came in at $501.4 million in Q2 2021, down 0.85% on a QoQ basis from $505.7 million in Q1 2021.
Warby Parker (WRBY) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
Warby Parker (WRBY) has 2 years of Preferred Stock Liabilities data on file, last reported at $501.4 million in Q2 2021.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $501.4 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $501.4 million (changed N/A YoY) and the FY2020 annual result came in at $506.5 million, up 92.7% from the prior year.
- Preferred Stock Liabilities slipped to $501.4 million in Q2 2021, from $505.7 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $506.5 million in Q3 2020 to a low of $501.4 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 501.44 Mn |
| Mar 31, 2021 | 505.72 Mn |
| Dec 31, 2020 | 506.51 Mn |
| Sep 30, 2020 | 506.54 Mn |